lorazepam / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   33 Trials   33 Trials   2235 News 


«12...25262728293031323334353637»
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion date, Trial primary completion date:  TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation (clinicaltrials.gov) -  Apr 19, 2019   
    P=N/A,  N=172, Recruiting, 
    These data suggest that cBZD exacerbates motoric aging in a manner that involves diminished TSPO, elevated Aβ, and mitochondrial damage. Trial completion date: Sep 2019 --> Dec 2020 | Trial primary completion date: Dec 2018 --> Mar 2020
  • ||||||||||  lorazepam / Generic mfg.
    Trial completion date, Trial primary completion date:  TAAT: Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome (clinicaltrials.gov) -  Apr 17, 2019   
    P4,  N=28, Recruiting, 
    No abstract available Trial completion date: Mar 2019 --> Jul 2020 | Trial primary completion date: Dec 2018 --> Jul 2020
  • ||||||||||  lorazepam / generics
    Journal:  Catatonia is not schizophrenia and it is treatable. (Pubmed Central) -  Apr 10, 2019   
    Eighty percent of the patients are relieved by the use of barbiturates or benzodiazepines, while in those who fail, an improvement is achieved by electroconvulsive therapy (ECT). With more than 60years of use in catatonic patients, ECT has proven to be an effective and safe tool for the treatment of this frequent and sometimes forgotten syndrome.
  • ||||||||||  lorazepam / Generic mfg.
    New trial:  LORA-PITA IV General Investigation (clinicaltrials.gov) -  Apr 5, 2019   
    P,  N=200, Not yet recruiting, 
  • ||||||||||  ketamine / Generic mfg., phenobarbital / Generic mfg.
    Trial initiation date:  PKAT: Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine (clinicaltrials.gov) -  Apr 4, 2019   
    P4,  N=222, Not yet recruiting, 
    With more than 60years of use in catatonic patients, ECT has proven to be an effective and safe tool for the treatment of this frequent and sometimes forgotten syndrome. Initiation date: Mar 2019 --> Jun 2019
  • ||||||||||  gabapentin / Generic mfg.
    Trial completion date, Trial primary completion date:  Gabapentin for Alcohol Withdrawal Syndrome (clinicaltrials.gov) -  Feb 27, 2019   
    P4,  N=400, Recruiting, 
    Phase classification: P2 --> P1 Trial completion date: Dec 2019 --> Dec 2021 | Trial primary completion date: Feb 2019 --> Feb 2021
  • ||||||||||  lorazepam / Generic mfg.
    Enrollment open:  PSILOCD: Psilocybin for Treatment of Obsessive Compulsive Disorder (clinicaltrials.gov) -  Feb 7, 2019   
    P2,  N=15, Recruiting, 
    Trial completion date: Dec 2019 --> Dec 2021 | Trial primary completion date: Feb 2019 --> Feb 2021 Not yet recruiting --> Recruiting
  • ||||||||||  lorazepam / Generic mfg., diazepam / Generic mfg., alprazolam / Generic mfg.
    Trial completion:  Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (clinicaltrials.gov) -  Oct 16, 2018   
    P1,  N=480, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  lorazepam / Generic mfg., diazepam / Generic mfg., alprazolam / Generic mfg.
    Trial primary completion date:  Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (clinicaltrials.gov) -  Aug 15, 2018   
    P1,  N=480, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Apr 2018 --> Aug 2018
  • ||||||||||  Recentin (cediranib) / AstraZeneca
    Trial completion date, Trial primary completion date, Monotherapy, Metastases:  Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) -  Jul 19, 2018   
    P2,  N=70, Recruiting, 
    Trial primary completion date: Apr 2018 --> Aug 2018 Trial completion date: Jun 2019 --> Dec 2019 | Trial primary completion date: Jun 2019 --> Dec 2019
  • ||||||||||  Gralise (gabapentin) / Alvogen
    Trial termination:  Stanford Accelerated Recovery Trial (START) (clinicaltrials.gov) -  Jun 28, 2018   
    P3,  N=422, Terminated, 
    Trial completion date: Jun 2019 --> Dec 2019 | Trial primary completion date: Jun 2019 --> Dec 2019 Active, not recruiting --> Terminated; Trial met futility stopping point
  • ||||||||||  Recentin (cediranib) / AstraZeneca
    Trial primary completion date, Monotherapy, Metastases:  Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) -  Jun 28, 2018   
    P2,  N=70, Recruiting, 
    Active, not recruiting --> Terminated; Trial met futility stopping point Trial primary completion date: Jun 2018 --> Jun 2019
  • ||||||||||  ketamine / Generic mfg.
    Enrollment closed, Trial primary completion date:  Treatment Resistant Depression (Pilot) (clinicaltrials.gov) -  Jun 20, 2018   
    P=N/A,  N=40, Active, not recruiting, 
    Trial primary completion date: Jun 2018 --> Jun 2019 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2018 --> Jun 2019
  • ||||||||||  OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
    Trial completion date, Trial primary completion date:  OSDI: Oral Sedation During Cervical Dilator Placement (clinicaltrials.gov) -  Jun 6, 2018   
    P4,  N=60, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2018 --> Jun 2019 Trial completion date: Oct 2018 --> Jul 2019 | Trial primary completion date: Sep 2018 --> Jun 2019
  • ||||||||||  Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma, NN1213 / Novo Nordisk
    Trial primary completion date:  Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) -  Jun 4, 2018   
    P=N/A,  N=109, Active, not recruiting, 
    Trial completion date: Oct 2018 --> Jul 2019 | Trial primary completion date: Sep 2018 --> Jun 2019 Trial primary completion date: May 2018 --> Dec 2019
  • ||||||||||  Adasuve (staccato loxapine) / AOP Orphan Pharma, Teva, Ferrer International, Galen, Medivir
    Enrollment change, Trial completion date, Trial termination, Trial primary completion date, Head-to-Head:  Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation (clinicaltrials.gov) -  Apr 6, 2018   
    P4,  N=2, Terminated, 
    Trial completion date: Dec 2017 --> Jun 2018 | Trial primary completion date: Dec 2017 --> Jun 2018 N=140 --> 2 | Trial completion date: Aug 2019 --> Apr 2018 | Recruiting --> Terminated | Trial primary completion date: Aug 2019 --> Apr 2018; Sponsor Withdrawal
  • ||||||||||  Recentin (cediranib) / AstraZeneca
    Trial completion date, Monotherapy, Metastases:  Sunitinib or Cediranib for Alveolar Soft Part Sarcoma (clinicaltrials.gov) -  Mar 12, 2018   
    P2,  N=70, Recruiting, 
    N=140 --> 2 | Trial completion date: Aug 2019 --> Apr 2018 | Recruiting --> Terminated | Trial primary completion date: Aug 2019 --> Apr 2018; Sponsor Withdrawal Trial completion date: Jun 2018 --> Jun 2019
  • ||||||||||  OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
    Trial primary completion date:  OSDI: Oral Sedation During Cervical Dilator Placement (clinicaltrials.gov) -  Jan 29, 2018   
    P4,  N=60, Recruiting, 
    Trial completion date: Jun 2018 --> Jun 2019 Trial primary completion date: Feb 2018 --> Sep 2018
  • ||||||||||  Adasuve (staccato loxapine) / AOP Orphan Pharma, Teva, Ferrer International, Galen, Medivir
    Phase classification:  ADASUVE-Lorazepam Drug-Drug Interaction (clinicaltrials.gov) -  Dec 13, 2017   
    P4,  N=22, Completed, 
    Trial primary completion date: Feb 2018 --> Sep 2018 Phase classification: P1 --> P4
  • ||||||||||  lorazepam / Generic mfg., diazepam / Generic mfg., alprazolam / Generic mfg.
    Enrollment open, Trial initiation date:  Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) (clinicaltrials.gov) -  Nov 20, 2017   
    P1,  N=480, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Sep 2017 --> Apr 2017
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date, Adverse events:  Pharmacovigilance in Gerontopsychiatric Patients (clinicaltrials.gov) -  Oct 19, 2017   
    P3,  N=407, Terminated, 
    Not yet recruiting --> Recruiting | Initiation date: Sep 2017 --> Apr 2017 N=2000 --> 407 | Recruiting --> Terminated | Trial primary completion date: Feb 2017 --> Jun 2017
  • ||||||||||  Adasuve (staccato loxapine) / AOP Orphan Pharma, Teva, Ferrer International, Galen, Medivir
    Enrollment open, Head-to-Head:  Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation (clinicaltrials.gov) -  Oct 19, 2017   
    P4,  N=140, Recruiting, 
    N=2000 --> 407 | Recruiting --> Terminated | Trial primary completion date: Feb 2017 --> Jun 2017 Not yet recruiting --> Recruiting
  • ||||||||||  Onsolis (BEMA fentanyl) / Viatris, Collegium Pharma
    Phase classification, Trial primary completion date:  Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD) (clinicaltrials.gov) -  Aug 22, 2017   
    P=N/A,  N=109, Active, not recruiting, 
    Not yet recruiting --> Recruiting Phase classification: P1 --> P=N/A | Trial primary completion date: Apr 2017 --> May 2018
  • ||||||||||  Adasuve (staccato loxapine) / AOP Orphan Pharma, Teva, Ferrer International, Galen, Medivir
    Trial initiation date, Trial primary completion date, Head-to-Head:  Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation (clinicaltrials.gov) -  Jul 11, 2017   
    P4,  N=140, Not yet recruiting, 
    Phase classification: P1 --> P=N/A | Trial primary completion date: Apr 2017 --> May 2018 Initiation date: May 2017 --> Aug 2017 | Trial primary completion date: Apr 2019 --> Aug 2019
  • ||||||||||  OxiFast (oxycodone immediate release) / Purdue, Shionogi, Mundipharma
    Enrollment open:  OSDI: Oral Sedation During Cervical Dilator Placement (clinicaltrials.gov) -  Jul 2, 2017   
    P4,  N=60, Recruiting, 
    Initiation date: May 2017 --> Aug 2017 | Trial primary completion date: Apr 2019 --> Aug 2019 Not yet recruiting --> Recruiting
  • ||||||||||  dextromethorphan / Generic mfg.
    Trial completion:  Dextromethorphan to Treat Patients With Voice Spasms (clinicaltrials.gov) -  Jun 30, 2017   
    P1,  N=65, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed